Search Grant Opportunities

Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)

ID: RFA-AI-18-015 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

This Funding Opportunity Announcement (FOA) solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress virus in HIV-infected individuals. The FOA will support small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control. Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 4/25/18 the National Institutes of Health posted grant opportunity RFA-AI-18-015 for Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required) with funding of $3.2 million. The grant will be issued under grant program 93.855 Allergy and Infectious Diseases Research.

Timing

Posted Date
April 25, 2018, 12:00 a.m. EDT
Closing Date
Sept. 27, 2018, 12:00 a.m. EDT Past Due
Version
1
Archive Date
Nov. 2, 2018

Eligibility

Eligible Applicants
Small businesses
Special district governments
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
For profit organizations other than small businesses
City or township governments
Public housing authorities/Indian housing authorities
Others (see text field entitled "Additional Information on Eligibility" for clarification)
State governments
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$3,200,000
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405

Documents

Posted documents for RFA-AI-18-015

Grant Awards

Grants awarded through RFA-AI-18-015

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-AI-18-015

Experts for Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)

Recommended subject matter experts available for hire